MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Stellar Biotechnologies Company Profile (NASDAQ:SBOT)

Consensus Ratings for Stellar Biotechnologies (NASDAQ:SBOT) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (276.11% upside)

Analysts' Ratings History for Stellar Biotechnologies (NASDAQ:SBOT)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Stellar Biotechnologies (NASDAQ:SBOT)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Stellar Biotechnologies (NASDAQ:SBOT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)
Dividend History for Stellar Biotechnologies (NASDAQ:SBOT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Stellar Biotechnologies (NASDAQ:SBOT)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Stellar Biotechnologies (NASDAQ:SBOT)
DateHeadline
06/26/16 10:41 AMStellar Bio bucks the market, shares up 20% - Seeking Alpha
06/26/16 10:41 AMTyco International plc (NYSE:TYC) Went Up 1.15%: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Anika Therapeutics ... - KC Register
06/26/16 10:41 AMShare Volatility Check for: Stellar Biotechnologies, Inc. (:SBOT) - Press Telegraph
06/24/16 08:52 AMStellar Biotechnologies: Vaccine Tech Buoyed By Partnerships - Seeking Alpha
06/23/16 08:00 AMMaxim's Jason McCarthy Interviewed by The Life Sciences Report - [Marketwired] - Maxim Analyst Jason McCarthy sees nothing but blue sky for Stellar Biotechnologies Inc., even though its product originated in the deep blue sea. With blockbuster indications like cancer, lupus and Alzheimer's ...
06/04/16 09:15 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Short Interest Decreased By 2.91% - HNN
06/02/16 06:46 PMStellar Biotechnologies to Present at LD Micro Invitational Conference - Marketwired (press release) - Stellar Biotechnologies to Present at LD Micro Invitational ConferenceMarketwired (press release)PORT HUENEME, CA--(Marketwired - Jun 2, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that the Company will present ...and more »
06/02/16 09:21 AMStellar Biotechnologies to Present at LD Micro Invitational Conference - Digital Journal - Stellar Biotechnologies to Present at LD Micro Invitational ConferenceDigital JournalPORT HUENEME, CA--(Marketwired - Jun 2, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") ( NASDAQ : SBOT ), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that the Company will present ...and more »
06/02/16 07:05 AMStellar Biotechnologies to Present at LD Micro Invitational Conference - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 06/02/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'the Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), today ...
05/25/16 09:45 AMStellar Biotechnologies Named as a 2016 California Small Business of the Year - Marketwired (press release) - Stellar Biotechnologies Named as a 2016 California Small Business of the YearMarketwired (press release)PORT HUENEME, CA--(Marketwired - May 25, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), announced that the Company will be recognized ...and more »
05/25/16 08:16 AMStellar Biotechnologies Named as a 2016 California Small Business of the Year - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/25/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), announced ...
05/23/16 09:51 AMStellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls ... - Marketwired (press release) - Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls ...Marketwired (press release)PORT HUENEME, CA--(Marketwired - May 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced the appointment of Michael L.and more »
05/23/16 09:51 AMInvestors Alert: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Kitov Pharmaceuticals Holdings LTD (NASDAQ:KTOV ... - KC Register - Investors Alert: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Kitov Pharmaceuticals Holdings LTD (NASDAQ:KTOV ...KC RegisterOn 9 May, Stellar Biotechnologies, Inc. (NASDAQ:SBOT) reported Total expenses were $1.42 million and $3.22 million for the second quarter and six months ended March 31, 2016, compared to $1.38 million and $2.92 million for the same periods in 2015.and more »
05/23/16 07:46 AMStellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC) - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/23/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), today ...
05/20/16 09:52 AMAnalysts Offer Insights on Healthcare Companies: Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc ... - Analyst Ratings - Analysts Offer Insights on Healthcare Companies: Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc ...Analyst RatingsThere's a lot to be optimistic about in the Healthcare sector as 2 experts just weighed in on Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc (NASDAQ: SBOT) with bullish sentimens. Check-Cap Ltd. (NASDAQ: CHEK). In a report released ...
05/19/16 10:00 AMMorning Stocks Movement: Big Gainers - TISA, CLWT, CETX, PULM, SMT, RXII, RPRX - FxPips.com - Morning Stocks Movement: Big Gainers - TISA, CLWT, CETX, PULM, SMT, RXII, RPRXFxPips.comVenaxis Inc (APPY) traded at $3.90 + 0.31 (8.64 pct) on 74,865 total stock volume. The company is +60.10 pct year-to-date, and -5.54 pct during the past four quarters. Stellar Biotechnologies Inc (SBOT) traded at $3.36 + 0.25 (8.04 pct) on 3,800 total ...and more »
05/17/16 03:33 PMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial -
05/16/16 09:30 AMSBOT: JV Consummated, Neovacs' Lupus Candidate Closer to Commercialization -
05/12/16 10:32 AMStellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2016 By the Numbers -
05/12/16 09:23 AMNeovacs : Néovacs et Stellar Biotechnologies signent leur accord définitif pour créer Neostell SAS - Zonebourse.com - Neovacs : Néovacs et Stellar Biotechnologies signent leur accord définitif pour créer Neostell SASZonebourse.com... Stellar Biotechnologies Inc. ("Stellar") (Nasdaq: SBOT), qui détermine la création de la société de production Neostell SAS sous forme d'une joint-venture, basée en région parisienne, détenue à 70% par Néovacs et 30% par Stellar Biotechnologies.and more »
05/12/16 09:23 AMStellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ... - Marketwired (press release) - Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ...Marketwired (press release)PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - May 11, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV) today announced their entry into a joint venture ...
05/12/16 09:23 AMNeovacs and Stellar Biotechnologies sign a joint venture agreement to create Neostell SAS - Yahoo Finance UK - Neovacs and Stellar Biotechnologies sign a joint venture agreement to create Neostell SASYahoo Finance UK... company Stellar Biotechnologies Inc. ("Stellar") (Nasdaq: SBOT), to determine the creation of the production company Neostell SAS under a form of a joint venture, based in the Paris area and owned 70% by Neovacs and 30% by Stellar Biotechnologies.Stellar Biotechnologies Shares Rise More Than 2% on JV With Neovacs to Make Conjugated Therapeutic Vaccines ...Sonoran Weekly ReviewStellar Biotechnologies' (SBOT) CEO Frank Oakes on Q2 2016 Results - Earnings Call TranscriptSeeking AlphaStellar Biotechnologies Inc's Trend Up, Especially After Today's Strong SessionFranklin Independentall 5 news articles »
05/12/16 04:17 AMNeovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS - [at noodls] - Paris and Boston, May 12, 2016 - Neovacs (Alternext Paris: ALNEV)a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that the Company has finalized the terms of its ...
05/11/16 09:29 AMStellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ... - Digital Journal - Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ...Digital JournalPORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - May 11, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT ) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV) today announced their entry into a joint venture ...
05/11/16 09:05 AM10:05 am Stellar Biotechnologies enters JV w/ Neovacs to manufacture and sell conjugated therapeutic vaccines using its proprietary Keyhole Limpet Hemocyanin -
05/11/16 09:02 AMStellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM) - [Marketwired] - Stellar Biotechnologies, Inc. and Neovacs S.A. today announced their entry into a joint venture agreement to manufacture and sell conjugated therapeutic vaccines using Stellar's proprietary Keyhole Limpet ...
05/10/16 09:33 AMStellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights - Marketwired (press release) - Stellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational HighlightsMarketwired (press release)PORT HUENEME, CA--(Marketwired - May 9, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), announces its financial results for its second ...and more »
05/10/16 05:06 AMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements -
05/09/16 05:08 PMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report -
05/09/16 04:28 PMStellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/09/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'the Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), announces ...
05/08/16 08:56 AMRise Expected for Stellar Biotechnologies Inc (SBOT) EPS - B.O.D.Y Confidential - Rise Expected for Stellar Biotechnologies Inc (SBOT) EPSB.O.D.Y ConfidentialWall Street await Stellar Biotechnologies Inc (SBOT) to release earnings on May, 9. After posting $-0.19 EPS for the previous quarter, Stellar Biotechnologies Inc's analysts now forecast -5.26% EPS growth. The stock decreased 1.93% or $0.06 on May 6, ...and more »
05/03/16 09:09 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Shorted Shares Increased 17.1% After Market Selling - B.O.D.Y Confidential - Stellar Biotechnologies Incorporated (NASDAQ:SBOT) Shorted Shares Increased 17.1% After Market SellingB.O.D.Y ConfidentialThe short interest to Stellar Biotechnologies Incorporated's float is 0.36%. The stock decreased 10.00% or $0.35 on May 2, hitting $3.15. About 107,675 shares traded hands or 65.19% up from the average. Stellar Biotechnologies Inc (NASDAQ:SBOT) has ...Stellar Biotechnologies Announces Second Quarter 2016 Corporate Update Conference CallMarketwired (press release)all 2 news articles »
05/03/16 07:40 AMStellar Biotechnologies Announces Second Quarter 2016 Corporate Update Conference Call - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/03/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'the Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), will ...
05/02/16 09:54 AMFast Moving Stocks: Global Blood Therapeutics, Inc. (NASDAQ:GBT), Stellar Biotechnologies, Inc. (NASDAQ:SBOT ... - KC Register - Fast Moving Stocks: Global Blood Therapeutics, Inc. (NASDAQ:GBT), Stellar Biotechnologies, Inc. (NASDAQ:SBOT ...KC RegisterGlobal Blood Therapeutics Inc (NASDAQ:GBT)'s stock had its “outperform” rating restated by research analysts at Cowen and Company in a research report issued on Thursday. They presently have a $80.00 price target on the stock. Cowen and Company's ...and more »
04/30/16 09:15 AMIs Selling Stellar Biotechnologies Inc Here a Winning Strategy? - B.O.D.Y Confidential - Is Selling Stellar Biotechnologies Inc Here a Winning Strategy?B.O.D.Y ConfidentialThe stock of Stellar Biotechnologies Inc (NASDAQ:SBOT) is a huge mover today! The stock decreased 5.51% or $0.21 on April 29, hitting $3.6. About 55,372 shares traded hands. Stellar Biotechnologies Inc (NASDAQ:SBOT) has declined 56.63% since ...
04/08/16 08:55 AMWhat's Propelling Stellar Biotechnologies Inc to Increase So Much? - Business Standard Tribune - What's Propelling Stellar Biotechnologies Inc to Increase So Much?Business Standard TribuneThe stock of Stellar Biotechnologies Inc (NASDAQ:SBOT) is a huge mover today! The stock is up 3.84% or $0.15 after the news, hitting $4.13 per share. About 61,401 shares traded hands or 16.07% up from the average. Stellar Biotechnologies Inc ...Watch List: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), Covenant ...KC Registerall 3 news articles »
04/06/16 08:49 AMTop-Rated Stock Picks and Most-Read Stories at Nasdaq.com: March 27 - April 2 - Nasdaq - Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: March 27 - April 2NasdaqGlobal X Lithium ETF (LIT): Lithium is the next metal oil. Coca-Cola Bottling Co. (COKE): Mainly because they have been doing great on earnings and generating more profits every quarter. Stellar Biotechnologies (SBOT): Unique product with gaining ...
04/06/16 08:49 AMStellar Biotechnologies: Cures for Cancer, Alzheimer's Disease, Lupus, and More Underscore the Critical Need to ... - CountingPips (blog) - Stellar Biotechnologies: Cures for Cancer, Alzheimer's Disease, Lupus, and More Underscore the Critical Need to ...CountingPips (blog)Before forming Stellar Biotechnologies Inc. (SBOT:NASDAQ), I had over 35 years of management experience in developing aquaculture technology and domesticating marine species. For 10 years I was the CEO of The Abalone Farm Inc., the country's largest ...
04/05/16 08:35 AMMarket Activity: 52-week Lows – WSCI, VRX, SBOT, LIVN, VSLR, ESTE, ORPN, RAIL, VRTS, DAC - FxPips.com - Market Activity: 52-week Lows – WSCI, VRX, SBOT, LIVN, VSLR, ESTE, ORPN, RAIL, VRTS, DACFxPips.comValeant Pharmaceuticals International Inc (VRX) registered a new low of 25.27 above a previous 52 week low of 25.75. The company traded at $25.87 – 2.2301 (7.94 percent) on 24,372,862 total share volume. Stellar Biotechnologies Inc (SBOT) registered a ...
04/05/16 08:35 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Short Interest Increased By 122.99% - Clinton Financial - Stellar Biotechnologies Incorporated (NASDAQ:SBOT) Short Interest Increased By 122.99%Clinton FinancialThe short interest to Stellar Biotechnologies Incorporated's float is 0.62%. The stock decreased 7.87% or $0.37 on April 4, hitting $4.33. About 65,294 shares traded hands or 132.45% up from the average. Stellar Biotechnologies Inc (NASDAQ:SBOT) has ...
03/31/16 08:28 AMThe 52-Week Low Club for Wednesday - 24/7 Wall St. - The 52-Week Low Club for Wednesday24/7 Wall St.Stellar Biotechnologies Inc. (NASDAQ: SBOT) dropped about 16% on Wednesday to post a new 52-week low of $4.44 against a 52-week high of $10.98. The stock closed at $5.29 on Tuesday night. Volume totaled about 105,000 shares compared with the ...and more »
03/31/16 08:28 AMStellar Biotechnologies Inc (NASDAQ:SBOT)'s Company Shares Decreased 20.93% After Low Volatility - Stock Caller - Stellar Biotechnologies Inc (NASDAQ:SBOT)'s Company Shares Decreased 20.93% After Low VolatilityStock CallerThe shares of Stellar Biotechnologies Inc (NASDAQ:SBOT) decreased by 20.93% in the last 20 days and lost 5.54% in the past 5 trading sessions. Stellar Biotechnologies Inc (NASDAQ:SBOT) shares opened at $5.54 in the last session and had intraday high ...Stellar Biotechnologies To Voluntarily Delist From TSX Venture Exchange (NASDAQ:SBOT)Sonoran Weekly ReviewStellar Biotechnologies Incorporated (NASDAQ:SBOT) Sellers Increased By 122.99% Their ShortsBusiness Standard TribuneToday's Stocks: Stellar Biotechnologies, (NASDAQ:SBOT), WPX Energy, (NYSE:WPX), 1st Century Bancshares ...Benchmark Monitorall 7 news articles »
03/30/16 08:36 AMStellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting - Stockhouse - Stellar Biotechnologies' Announces Effective Date of TSX-V Voluntary DelistingStockhousePORT HUENEME, CA--(Marketwired - Mar 29, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT ) ( TSX VENTURE : KLH ), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin, today announced that the Company's voluntary ...and more »
03/29/16 04:10 PMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events -
03/29/16 04:07 PMStellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 03/29/16 -- Stellar Biotechnologies, Inc. ('Stellar') (NASDAQ: SBOT) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin, today announced ...
03/25/16 08:39 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Shorted Shares Increased By 8.07% - Clinton Financial - Stellar Biotechnologies Incorporated (NASDAQ:SBOT) Shorted Shares Increased By 8.07%Clinton FinancialThe short interest to Stellar Biotechnologies Incorporated's float is 0.28%. The stock increased 4.10% or $0.21 on March 24, hitting $5.33. About 20,773 shares traded hands. Stellar Biotechnologies Inc (NASDAQ:SBOT) has declined 25.97% since August 19, ...
03/24/16 08:59 AMForm 8-K Stellar Biotechnologies, For: Mar 23 - StreetInsider.com - Pacific Coast Business TimesForm 8-K Stellar Biotechnologies, For: Mar 23StreetInsider.comPORT HUENEME, CA -- (Marketwired - March 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar") (NASDAQ: SBOT) (TSX VENTURE: KLH) announced that it has applied for voluntary delisting of the Company's common shares ("Shares") from the TSX Venture ...TSXV-Listed Stellar Biotechnologies to Delist Voluntarily From The TSXV (CVE:KLH)Sonoran Weekly Reviewall 5 news articles »
03/24/16 08:59 AMStellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange - Marketwired (press release) - Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture ExchangeMarketwired (press release)PORT HUENEME, CA--(Marketwired - Mar 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT) (TSX VENTURE: KLH) announced that it has applied for voluntary delisting of the Company's common shares ("Shares") from the TSX Venture ...
03/23/16 08:03 AMStellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange - Stockhouse - Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture ExchangeStockhousePORT HUENEME, CA--(Marketwired - Mar 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT ) ( TSX VENTURE : KLH ) announced that it has applied for voluntary delisting of the Company's common shares ("Shares") from the TSX Venture ...and more »
02/12/16 12:04 PMSTELLAR BIOTECHNOLOGIES, INC. Financials -
About Stellar Biotechnologies

Stellar Biotechnologies, Inc. (Stellar) is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH) protein. KLH is a high molecular weight and immune-stimulating protein. It operates under the brand name Stellar KLH. Its products include Stellar KLH protein in various grades, formulations and configurations for both clinical and preclinical applications. Stellar KLH can be used for therapeutic vaccine conjugation, as a carrier molecule in immunotherapies and as an immune stimulant in immunotoxicology applications. KLH can be used as an active pharmaceutical ingredient and combined with a disease-targeting agent to create immunotherapies targeting cancer, immune disorders, Alzheimer's disease and inflammatory diseases, or it can be used as a finished, injectable product in the immunodiagnostic market for measuring immune response in patients and research settings.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SBOT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.52
  • 50 Day Moving Average: $3.13
  • 200 Day Moving Average: $5.07
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $38.18M
  • Current Quarter EPS Consensus Estimate: $-0.51 EPS
Additional Links:
Stellar Biotechnologies (NASDAQ:SBOT) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha